Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.
Nontuberculous mycobacteria (NTM) are recognized as emerging pathogens. NTM disease in transplant recipients remains a diagnostic and therapeutic challenge. Herein, a review of the most recent literature will provide an update in regard to the epidemiology, clinical presentation, diagnosis, treatment, and prevention of NTM disease in solid organ and hematopoietic stem cell transplant recipients. Special consideration will be given to the lung transplant population.